Category: Science Blog October 27, 2014
We take a look at what the recently published NHS ‘Five Year Forward View’ means for cancer care within the health service in England.
Category: Science Blog October 24, 2014
Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK?
Category: Science Blog October 21, 2014
Our latest funding scheme focuses on the emerging field of biotherapeutics – smarter cancer treatments based on cells and biological molecules.
Category: Science Blog October 3, 2014
To mark the launch of our latest Citizen Science game, Reverse The Odds, we caught up with one the researchers that you’ll be helping by playing the game.
Category: Science Blog September 29, 2014
Something extraordinary is happening right now. Impelled by the Ebola outbreak in West Africa, researchers, medics, funding agencies, pharmaceutical companies a...
Category: Science Blog September 25, 2014
It may seem as though we’re constantly asked to give feedback – but what’s more important is knowing what’s happened as a result of our comments –...